Prevention of Cervical Cancer

Autor: Hillemanns, Peter, Friese, Klaus, Dannecker, Christian, Klug, Stefanie, Seifert, Ulrike, Iftner, Thomas, Hädicke, Juliane, Löning, Thomas, Horn, Lars, Schmidt, Dietmar, Ikenberg, Hans, Steiner, Manfred, Freitag, Ulrich, Siebert, Uwe, Sroczynski, Gaby, Sauerbrei, Willi, Beckmann, Matthias W., Gebhardt, Marion, Friedrich, Michael, Münstedt, Karsten, Schneider, Achim, Kaufmann, Andreas, Petry, K. Ulrich, Schäfer, Axel P. A., Pawlita, Michael, Weis, Joachim, Mehnert, Anja, Fehr, Mathias, Grimm, Christoph, Reich, Olaf, Arbyn, Marc, Kleijnen, Jos, Wesselmann, Simone, Nothacker, Monika, Follmann, Markus, Langer, Thomas, Jentschke, Matthias

Publikováno v: Geburtshilfe und Frauenheilkunde

Aims Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an important need, outlined in the National Cancer Plan, with regard to screening for cervical cancer, as this gui

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::06e8f306a7f33eafa8583d6eaa556240
http://europepmc.org/articles/PMC6379166

Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are Unsatisfactory

Autor: Petra Kohlberger, Karl Tamussino, Anton Graf, Peter Regitnig, Alexander Reinthaller, Lukas Hefler, Andreas Widschwendter, Wolfgang Pokieser, Thomas Fiedler, Wolfgang Eppel, Christian Marth, Olaf Reich, Georg Braune, Heinz Kölbl, Elmar A. Joura, Alain G. Zeimet

Publikováno v: Geburtshilfe und Frauenheilkunde

Purpose On January 1st, 2018, the ÖGZ (Austrian Society of Cytology) revised its cytological nomenclature to make it more similar to the 2015 Bethesda system. Following these changes, the Austrian Society of Gynecology and Obstetrics felt it necessa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34697a53b7058144f6161fdf2c963eb7
https://doi.org/10.1055/a-0764-4875

Entscheidungsanalytische Modellierung zur Evaluation der Langzeit-Effektivität und Kosten-Effektivität des Einsatzes der HPV-DNA-Diagnostik im Rahmen der Zervixkarzinomfrüherkennung in Deutschland

Autor: Sroczynski, Gaby, Schnell-Inderst, Petra, Muhlberger, Nikolai, Lang, Katharina, Aidelsburger, Pamela, Wasem, Jurgen, Mittendorf, Thomas, Engel, Jutta, Hillemanns, Peter, Petry, Karl Ulrich, Krämer, Alexander, Siebert, Uwe

Publikováno v: GMS Health Technology Assessment
GMS Health Technology Assessment, Vol 6, p Doc05 (2010)
GMS Health Technology Assessment; VOL: 6; DOC05 /20100427/

Background Persistent infections with high-risk types of human papillomavirus (HPV) are associated with the development of cervical neoplasia. Compared to cytology HPV testing is more sensitive in detecting high-grade cervical cancer precursors, but

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a61ce08b0c1f4cd54617636c3575c88
https://pubmed.ncbi.nlm.nih.gov/21289878

Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer

Autor: Nocon, M, Mittendorf, T, Roll, S, Greiner, W, Willich, SN, von der Schulenburg, JM

Publikováno v: GMS Health Technology Assessment; VOL: 3; DOC07 /20070810/

Introduction With 3.2% of all cancer cases in 2002, cervical carcinoma is the tenth most common cancer in Germany and causes 1.8% of all cancer deaths in women in Germany. To date diagnosis in Germany solely has been based on cervical cytology which

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1175::9d26a12506083f6ffb729ae439ecfc6e
http://www.egms.de/en/journals/hta/2007-3/hta000042.shtml

Autor: Betschart C; 1 Klinik für Gynäkologie, Universitätsspital Zürich., Ghisu GP; 1 Klinik für Gynäkologie, Universitätsspital Zürich., Fink D; 1 Klinik für Gynäkologie, Universitätsspital Zürich.

Publikováno v: Praxis [Praxis (Bern 1994)] 2016 Nov; Vol. 105 (23), pp. 1363-1369.